A Systematic Review of Management of Cramping Pain in Patients with Amyotrophic Lateral Sclerosis
European Neurology · 2025
DOI: 10.1159/000548820 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Neurology, 2025. Verfasst von Hannah Katherine Hall und 4 weiteren Autor:innen. Beteiligte Einrichtung: Macquarie University Medical School, Sydney, New South Wales, Australia, hannahkatherine.hall@students.mq.edu.au. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Pain Management, Muscle Cramp. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Pain, particularly cramping, in people living with amyotrophic lateral sclerosis (ALS) is often underrecognized and under-treated. Despite affecting over 70% of people living with ALS (plwALS), cramping pain remains inadequately managed due to its complex nature and the difficulties plwALS face in communicating their symptoms as the disease progresses. This systematic review explores both pharmacological and non-pharmacological treatments for cramping pain in ALS, aiming to assess and compare their efficacy.
Methods
The systematic review was conducted following PRISMA guidelines, and the protocol was registered with PROSPERO (ID CRD42024521649). A comprehensive search was performed across MEDLINE, Embase, Scopus, and Cochrane databases from inception until February 1, 2024, using specific search terms related to ALS and cramping.
Results
The search resulted in the identification of 368 studies. After duplicates were removed, abstracts screened, and full texts reviewed, nine studies were included. Pharmacological interventions such as mexiletine demonstrated significant reductions in cramp frequency and intensity in several trials, with varying doses showing distinct levels of effectiveness. Other medications like dronabinol and levetiracetam were also tested but showed limited efficacy in reducing cramp severity. Among non-pharmacological options, supervised exercise programs, particularly those incorporating stretching and functional mobility, were effective in reducing cramping pain intensity, while unsupervised home exercise programs did not show significant improvements.
Conclusion
The review demonstrates the scarcity of high-quality research on cramping pain management in ALS. Mexiletine emerged as the most promising pharmacological intervention, providing notable relief, while supervised exercise therapy demonstrated beneficial effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Macquarie University Medical School, Sydney, New South Wales, Australia, hannahkatherine.hall@students.mq.edu.au.
- Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia.
- Central Coast Local Health District, Gosford, New South Wales, Australia.
Zitieren
APA
Hall, H. K., Austin, E., Hutchinson, K., Cheek, C., & Clay-Williams, R. (2025). A Systematic Review of Management of Cramping Pain in Patients with Amyotrophic Lateral Sclerosis. European Neurology. https://doi.org/10.1159/000548820
Vancouver
Hall HK, Austin E, Hutchinson K, Cheek C, Clay-Williams R. A Systematic Review of Management of Cramping Pain in Patients with Amyotrophic Lateral Sclerosis. European Neurology. 2025. doi:10.1159/000548820
BibTeX
@article{Hall2025,
author = {Hall, Hannah Katherine and Austin, Elizabeth and Hutchinson, Karen and Cheek, Colleen and Clay-Williams, Robyn},
title = {A Systematic Review of Management of Cramping Pain in Patients with Amyotrophic Lateral Sclerosis},
journal = {European Neurology},
year = {2025},
doi = {10.1159/000548820}
}
EUVIMED